top of page
MO.jpg

IN THE STATES

MISSOURI

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Missouri in 2022.

MO.png

Economic
Output

$26.6B

Direct Jobs Supported by the Industry

17,141

Total Jobs Supported

86,066

State Total Vendor Relationships

854

State Total Vendor Spending

$1,023,189,686

Clinical
Trials

970

Investments at Clinical Trial Sites

$354M

Clinical Trial Participants

18,953

Total Economic Impact of Clinical Trial Sites

$981.1M

bottom of page